Cargando…

Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis

BACKGROUND: Esophageal carcinoma (EC) is the seventh-most prevalent tumor in the world, which is still one of the primary causes of tumor-related death. Identifying noteworthy biomarkers for EC is particularly significant in guiding effective treatment. Recently, circulating tumor cells (CTCs) in pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yiding, Wu, Guiling, Yang, Wanli, Wang, Xiaoqian, Duan, Lili, Niu, Liaoran, Zhang, Yujie, Liu, Jinqiang, Hong, Liu, Fan, Daiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310134/ https://www.ncbi.nlm.nih.gov/pubmed/32571299 http://dx.doi.org/10.1186/s12885-020-07059-x

Ejemplares similares

EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma
por: Duan, Lili, et al.
Publicado: (2020)

Effects of marital status on survival of retroperitoneal liposarcomas stratified by age and sex: A population‐based study
por: Li, Yiding, et al.
Publicado: (2022)

Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis
por: Li, Yiding, et al.
Publicado: (2022)

Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study
por: Li, Yiding, et al.
Publicado: (2022)

Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes
por: Duan, Lili, et al.
Publicado: (2021)

Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
por: Li, Yiding, et al.
Publicado: (2023)

Development and validation of a prognostic model to predict the prognosis of patients with colorectal gastrointestinal stromal tumor: A large international population-based cohort study
por: Li, Yiding, et al.
Publicado: (2022)

Biological Implications and Clinical Potential of Metastasis-Related miRNA in Colorectal Cancer
por: Niu, Liaoran, et al.
Publicado: (2020)

Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis
por: Yang, Wanli, et al.
Publicado: (2021)

Biological functions and theranostic potential of HMGB family members in human cancers
por: Niu, Liaoran, et al.
Publicado: (2020)

Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
por: Duan, Lili, et al.
Publicado: (2020)

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
por: Truini, Anna, et al.
Publicado: (2014)

In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
por: Hillig, Thore, et al.
Publicado: (2015)

Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis
por: Yang, Chaogang, et al.
Publicado: (2018)

Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
por: Yang, Wanli, et al.
Publicado: (2019)

Cell line dependent expression of EpCAM influences the detection of circulating tumor cells with CellSearch
por: Lindgren, Gustaf, et al.
Publicado: (2017)

Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA
por: Cao, Lu, et al.
Publicado: (2023)

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
por: Farace, F, et al.
Publicado: (2011)

Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS
por: Swennenhuis, Joost F, et al.
Publicado: (2013)

Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer
por: Ning, Dawei, et al.
Publicado: (2021)

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer
por: Miller, M. Craig, et al.
Publicado: (2010)

Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo
por: Raimondi, Cristina, et al.
Publicado: (2014)

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation
por: Frithiof, Henrik, et al.
Publicado: (2015)

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(®) System and the AdnaTest(®)
por: Gorges, Tobias M., et al.
Publicado: (2016)

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch(®) and ISET
por: Tamminga, Menno, et al.
Publicado: (2020)

Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells
por: Sheng, Yuan, et al.
Publicado: (2015)

Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System
por: Almici, Camillo, et al.
Publicado: (2019)

A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
por: Frithiof, Henrik, et al.
Publicado: (2016)

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
por: Dirix, Luc, et al.
Publicado: (2022)

Case Report: Detection and quantification of tumor cells in peripheral blood and ascitic fluid from a metastatic esophageal cancer patient using the CellSearch (® )technology
por: Tu, Qian, et al.
Publicado: (2014)

Preoperative CTC-Detection by CellSearch(®) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
por: Hugenschmidt, Harald, et al.
Publicado: (2021)

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer
por: Van der Auwera, I, et al.
Publicado: (2010)

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
por: Huebner, Hanna, et al.
Publicado: (2018)

Prognostic value of circulating tumor cells in esophageal cancer
por: Xu, Hai-Tao, et al.
Publicado: (2017)

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
por: Peeters, D J E, et al.
Publicado: (2013)

Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma
por: Liao, Yuehua, et al.
Publicado: (2017)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis
por: Wang, Shuyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d7gpviserd09mvrmep02dr8mbh